WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹3.98 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr | ₹44 Cr |
What is the latest Cash Flow from Operating Activities ratio of WANBURY ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹3.98 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹44 Cr |
How is Cash Flow from Operating Activities of WANBURY Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹3.98 Cr | -79.91 | |
Mar2023 | ₹20 Cr | -51.15 | |
Mar2022 | ₹41 Cr | 142.91 | |
Mar2021 | ₹17 Cr | -62.20 | |
Mar2020 | ₹44 Cr | - |
Compare Cash Flow from Operating Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹807.0 Cr | 2.6% | -23.4% | 84.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,123.0 Cr | -1.3% | -1.5% | 32.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,171.0 Cr | 2.7% | 1.2% | 51.4% | Stock Analytics | |
CIPLA | ₹116,579.0 Cr | -1.8% | -0.5% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,750.0 Cr | -3.8% | 4.4% | 17.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -1.5% | 2% | 40% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 2.6% |
-23.4% |
84.3% |
SENSEX | -0.7% |
-5.8% |
7.4% |
You may also like the below Video Courses